Managing therapeutic resistance in breast cancer: from the lncRNAs perspective

Breast cancer (BC) is the most common female malignancy and the second leading cause of cancer-related death worldwide. In spite of significant advances in clinical management, the mortality of BC continues to increase due to the frequent occurrence of treatment resistance. Intensive studies have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Liyuan, Jiang, Jingwen, Tang, Bo, Nice, Edouard C., Zhang, Yuan-Yuan, Xie, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482807/
https://www.ncbi.nlm.nih.gov/pubmed/32929354
http://dx.doi.org/10.7150/thno.49922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482807/
https://www.ncbi.nlm.nih.gov/pubmed/32929354
http://dx.doi.org/10.7150/thno.49922

Ejemplares similares